Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population

Journal of Medical Virology

Volumn 70, Issue 2, 2003, Pages 194-204

  Ördög, Katalin ^a   Szendrôi, Andrea ^b   Szarka, Katalin ^a   Kugler, Zoltán ^a   Csire, Márta ^b   Kapusinszky, Beatrix ^b   Xie, Jiuru ^b   Csizmadia, Katalin ^b   Brojnás, Judit ^b   Rusvai, Erzsébet ^b   Tempfli, Ágnes ^a   Berencsi, György ^b  

^a Natl Serv of the Chf Med Officer   (Hungary)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

Author keywords

Elimination of HBV carrier state; HBV carrier pregnant women; Transmission before the preventive immunization

Indexed keywords

BIOCHEMICAL MARKER; HEPATITIS A ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CORRELATION ANALYSIS; DNA DETERMINATION; FAMILY; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PREVALENCE; SEROCONVERSION; SUPERINFECTION; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FAMILY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE;

HEPATITIS A VIRUS; HEPATITIS B VIRUS;

EID: 0242416923     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10378     Document Type: Article

References (77)

1. Anderson KE, Stevens CE, Tsuei JJ, Lee W-C, Sun S-C, Beasley RP. 1975. Hepatitis B antigen in infants born to mothers with chronic hepatitis B antigenemia in Taiwan. Am J Dis Child 129:1389-1392.
2. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang SN, Chisari FV. 1993. Mechanism of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 178:1541-1554.
3. André FE, Zuckerman AJ. 1994. Protective efficacy of hepatitis B vaccines in neonates. J Med Virol 44:144-151.
4. Baginski I, Ferrie A, Watson R, Mack D. 1990. Detection of hepatitis B virus. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols. San Diego, CA: Academic Press. p 348-354.
5. Banatvala JE. 1996. Epidemiology of hepatitis A (HAV) in Europe and its relationship to immunisation. In: Buisson Y, Coursaget P, Kane M, editors. Enterically-transmitted hepatitis viruses. La Simmarre, Joué-lés-Tours. p 72-77.
6. Bancroft WH, Warkel RL, Talbert AA, Russell PK. 1971. Family with hepatitis-associated antigen. JAMA 217:1817-1820.
7. Beasley RP, Trepo C, Stevens CE, Szmuness W. 1977. The e antigen and the perinatal transmission of hepatitis B surface antigen. Am J Epidemiol 105:94-98.
8. Beasley RP, Hwang F-Y, Chen C-L. 1983. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2:1099-1102.
9. Berencsi G, Nagy GF. 1950. Hepatitis caused by injection syringe [in Hungarian]. Orvosi Hetilap 91:734-735.
10. Black FL, Hierholzer WJ, de Pinheiro F, Evans AS, Woodall JP, Opton EM, Emmons JE, West BS, Edsell G, Downs WG, Wallace GD. 1974. Evidence for persistence of infectious agents in isolated human population. Am J Epidemiol 100:230-250.
11. Bogomolski-Yahalom V, Granot E, Linder N, Adler R, Korman S, Manny N, Tur-Kaspa R, Shouval D. 1991. Prevalence of HBsAg-carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk. J Med Virol 34:217-222.
12. Burk RD, Hwang RY, Ho GY, Schafritz DA, Beasley RP. 1994. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 170:1418-1423.
13. Chisari FV. 1996. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 206:149-173.
14. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathology. Springer Semin Immunopathol 17:261-281.
15. Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Diesstag JL, Werner BG, Polk F, Snydman DR, Platt R, Crumpacker CS, Grady GF, Alper CA. 1986. Nonresponsiveness to hepatitis B vaccine of health care workers. Ann Intern Med 101:34-40.
16. Davis GL, Hoofnagle JH, Waggoner JG. 1984. Acute type A hepatitis during chronic hepatitis B infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon. J Med Virol 14:141-147.
17. Derso A, Boxall EH, Tarlow MJ, Flewett TH. 1978. Transmission of HBsAg from mother to infant in four ethnic groups. BMJ 1:949-952.
18. Esteban R. 1959. Risk of hepatitis B in infancy and childhood. Vaccine 13(suppl 1):35-36.
19. Ganem D. 1982. Persistent infection of humans with hepatitis B virus: mechanisms and consequences. Rev Infect Dis 4:1026-1047.
20. Gerety RJ, Schweitzer IL. 1977. Viral hepatitis type B during pregnancy, the neonatal period, and infancy. J Pediatr 90:368-372.
21. Grossman RA, Benenson MW, Scott RM, Snitbhan R, Top FH Jr, Pantuwatana S. 1975. An epidemiologic study of hepatitis B virus in Bankok, Thailand. Am J Epidemiol 107:144-160.
22. Guidotti LG, Ishikava T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
23. Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MB, Chisari FV. 1996. Viral cross-talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA 93:4589-4594.
24. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
25. Gussetti N, Pornaro E, Largajolli G, D'Elia R. 1983. Perinatal transmission of HBV from mothers HBsAg positive, anti-HBe positive. Dev Biol Stand 54:405-408.
26. Hadziyannis SJ, Merikas GE. 1970. Australia antigen in a family. Lancet 1:1057-1058.
27. Hardie DR, Kannemeyer J, Stannard LM. 1996. DNA single strand polymorphism identifies five defined strains of hepatitis B virus (HBV) during an outbreak of HBV infection in an oncology unit. J Med Virol 49:49-54.
28. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. 1991. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 13(suppl 4):105-107.
29. Heathcote J, Gateau P, Sherlock S. 1974. Role of the hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus. Lancet 2:370-372.
30. Heningst W. 1973. Sexual transmission of infections associated with hepatitis-B antigen. Lancet 2:1395.
31. Hepstonstall J. 1997. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 336:178-184.
32. Hersh T, Melnick JL, Goyal RK, Hollinger FB. 1971. Nonparenteral transmission of viral hepatitis type B (Australia antigen-associated serum hepatitis). N Engl J Med 285:1363-1364.
33. Irwin GR, Allen AM, Bancroft WH, Karwacki JJ, Pinkerton RH, Russell PK. 1974. Hepatitis B antigen and antibody: occurrence in families of asymptomatic HB Ag carriers. JAMA 227:1042-1043.
34. Kane M. 1995. Global programme for control of hepatitis B infection. Vaccine 13(suppl 1):47-49.
35. Kékesi Zs, Nika M, Mikola I. 1993. Experiences concerning the hepatitis B screening of pregnant women, and perinatal transmission of the virus [in Hungarian]. Orvosi Hetilap 134:1515-1520.
36. Kidd-Ljunggren K. 1996. Variability in hepatitis B virus DNA: phylogenetic, epidemiological and clinical implications. Scand J Infect Dis 28:111-116.
37. Koff RS, Slavin MM, Connelly LJD, Rosen DR. 1977. Contagiousness of acute hepatitis B: secondary attack rates in household contacts. Gastroenterology 72:297-300.
38. Kuru U, Turan O, Kuru N, Saglam Z, Ceylan Y, Nurluoglu M, Agacfidan A. 1996. Prevalence of hepatitis B virus infection in pregnant Turkish women and their families. Eur J Clin Microbiol Infect Dis 15:248-251.
39. Lee AKY, Ip HMH, Wong VCW. 1978. Mechanism of maternal-fetal transmission of hepatitis B virus. J Infect Dis 138:668-671.
40. Lin HH, Chang MH, Chen DS, Sung JL, Hong KH, Young YC, Yang KH, Lee TY. 1991. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 9:457-460.
41. Maupas P, Melnick JL. 1981. Hepatitis B infection and primary cancer. Prog Med Virol 27:1-5.
42. Mazzur S, Blumberg BS, Friedlaender J. 1974. Silent maternal transmission of Australia antigen. Nature 247:41-43.
43. Merrill DA, DuBois RS, Kohler PF. 1972. Neonatal onset of the hepatitis-associated antigen carrier state. N Engl J Med 287:1280-1282.
44. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. 1976. E antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of B virus to their infants. N Engl J Med 294:746-749.
45. Panda SK, Ramesh R, Rao KV, Gupta A, Zuckerman AJ, Nayak NC. 1991. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma derived hepatitis B vaccine in infants. J Med Virol 35:297-302.
46. Papaevangelou G, Hoofnagle J, Kremastinou J. 1974. Transplacental transmission of hepatitis-B virus by symptom-free chronic carrier mothers. Lancet 2:746-748.
47. Perrillo RP, Gelb L, Campbell C, Wellinghoff W, Ellis FR, Overby L, Aach RD. 1975. Hepatitis B e antigen, DNA polymerase activity and infection of household contacts with hepatitis B virus. Gastroenterology 76:1319-1325.
48. Pohl O, Brojnas J, Rusvai E, Ordog K, Siska I, Faludi G, Kapusinszky B, Csohan A, Mezey I, Berencsi Gy. 2001. Changes in the immunity to hepatitis A virus in the Hungarian population during the last 20 years: modifications in the active and passive immunisation procedures [in Hungarian]. Focus Med 3:3-11.
49. Reesink HW, Reerink-Brongers EE, Lafeber-Schut BJ, Kalshoven-Benschop J, Brummelhuis HG. 1979. Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin. Lancet 2:436-437.
50. Riley R, Maher C, Kolbe A. 1993. Hepatitis B vaccination of high-risk neonates in South West Region of New South Wales: evaluation of program coverage. Aust J Public Health 17:171-173.
51. Schaefer E, Koeppen H, Wirth S. 1993. Low level virus replication in infants with perinatally transmitted fulminant hepatitis and their anti-HBe positive mothers. Eur J Pediatr 152:581-584.
52. Schweitzer IL, Wing A, McPeak C, Spears RL. 1972. Hepatitis and hepatitis-associated antigen in 56 mother-infant pairs. JAMA 220:1092-1095.
53. Shiraki K, Yoshihara N, Kawana T, Yasui H, Sakurai M. 1977. Hepatitis B surface antigen and chronic hepatitis in infants born to asymptomatic carrier mothers. Am J Dis Child 131:644-647.
54. Sinatra FR, Shaw P, Weissman JY, Thomas DW, Merritt RJ, Tong MJ. 1982. Perinatal transmitted acute icteric hepatitis B in infants born to anti-hepatitis Be positive carrier mothers. Pediatrics 70:557-559.
55. Skinkoj P, Cohn J, Bradburne AF. 1976. Transmission of hepatitis type B from healthy HBsAg positive mothers. BMJ 2:10-11.
56. Soulie JC, Larsen M, Goudeau A, Parnet F, Dubois F, Pinon F, Huchet J, Brossard Y. 1991. The perinatal transmission of the hepatitis B virus in the Paris area [in French]. Ann Paediatr Paris 38:595-601.
57. Stevens CE, Toy PT, Taylor PE, Lee T, Yip HY. 1992. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics 90:170-173.
58. Straub I. 1996. Experiences of the introduction of country-wide programme for the prevention of hepatitis B virus infection of newborns [in Hungarian]. Epinfo 3:225-232.
59. Sumazaki R, Motz M, Wolf H, Heinig H, Jilg W, Deinhardt F. 1989. Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction. J Med Virol 27:304-308.
60. Szmuness W, Harley EJ, Prince AM. 1975. Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci 270:293-304.
61. Tada H, Uga N, Fuse Y, Shimizu M, Nemoto Y, Wakee E, Okamoto Y, Mishina J, Baba K. 1992. Prevention of perinatal transmission of hepatitis B virus carrier state. Acta Paediatr Jpn 34:656-659.
62. Tajiri H, Nose O, Shimizu K, Ida S, Miki K, Kimura S, Yabuuchi H. 1989. Prevention of neonatal HBV infection with the combination of HBIG and HBV vaccine and its long-term efficacy in infants borne to HBeAg positive HBV carrier mothers. Acta Paediatr Jpn 31:663-668.
63. Tajiri H, Kozaiwa K, Harada T, Ozaki Y, Miki K, Shimizu K, Okada S. 1991. Mass protection program of perinatal hepatitis B virus infection in Japan and impact of an optional booster vaccination on its efficacy. Acta Paediatr Jpn 33:323-326.
64. Tan CC, Guan R, Yap I, Tay HH, Kang JY. 1991. Horizontal, or perinatal transmission of hepatitis B virus? A serological survey in family members of hepatitis B carriers in Singapore. Trans R Soc Trop Med 85:656-659.
65. Tong MJ. 1989. Hepatitis B vaccination of neonates and children. Am J Med 87:33S-35S.
66. Tong MJ, Thursby M, Rakela J, McPeak C, Edwards VM, Mosley JW. 1981a. Studies, on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology 80:999-1004.
67. Tong MJ, Thursby MW, Lin J-H, Weissman JV, McPeak CM. 1981b. Studies on the maternal-infant transmission of the hepatitis B virus and HBV infection within families. Prog Med Virol 27:137-147.
68. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. 2001. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage under 5-years-old. Vaccine 19:3919-3926.
69. Valliammai T, Thyagarajan SP, Zuckerman AJ, Harrison TJ. 1995. Precore and core mutations in HBV from individuals in India with chronic infection. J Med Virol 45:321-325.
70. Van Damme P, Tormans G, Beutels P, Van Doorslaer E. 1995. Hepatitis B prevention in Europe. A preliminary economic evaluation. Vaccine 13(suppl 1):S54-S57.
71. Williams SJ, Craig PI, Liddle C, Batey RG, Farrell GC. 1987. Hepatitis B in Australia: determinants of intrafamily spread. Aust NZ J Med 17:220-227.
72. Williams JR, Nokes DJ, Medley GF, Anderson RM. 1996. The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating cost and effectiveness of immunization programmes. Epidemiol Infect 116:71-89.
73. Wong VCW, Ip HMH, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, Ma HK. 1984. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Lancet 2:921-926.
74. Xu ZY, Duan SC, Margolish HS, Purcell RH, On-yang PY, Coleman PJ, Zhuang YL, Xu HF, Quian SG, Zhu QR, Wan CY, Liu CB, Gun ZL, Huang CH, Zhang ZJ, Ren SL, Francis DP, Maynard JE, Gerin JL, Hadler SC, Fields HA, Johnson L. 1995. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. J Infect Dis 171:54-60.
75. Zuckerman AJ. 1975. Tissue and organ culture studies of hepatitis B virus. Am J Med Sci 270:197-204.
76. Zuckerman AJ. 1996. Development of new hepatitis B immunization strategies. Gut 38(suppl 2):60-62.
77. Zuckerman JN. 1996. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virol 50:283-288.